financetom
Business
financetom
/
Business
/
OpenAI launches new developer tools as Chinese AI startups gain ground
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OpenAI launches new developer tools as Chinese AI startups gain ground
Mar 11, 2025 11:42 AM

(Reuters) - OpenAI launched new tools for developers on Tuesday that will help them build advanced AI agents, using a few application programming interfaces (APIs), amid growing competition from Chinese AI startups.

AI agents are designed to independently execute complex real-world tasks without direct human intervention, while API is a strings of code which enables standardized communication, data exchange and functionality between software components.

The new tool, called the Responses API, is available to all developers at no additional cost. It replaces OpenAI's Assistants API, which is set to be phased out by the second half of 2026.

The development comes close on the heels of release of latest AI models by Chinese startups which claim to be on par or better than industry-leading models in the United States at a fraction of the cost.

Chinese startup Monica has grabbed attention over the past few days after its launched its autonomous AI agent Manus, weeks after DeepSeek was showered with praise by Silicon Valley executives and U.S. tech company engineers.

Monica, which claims that its Manus AI outperforms OpenAI's DeepResearch agent, said on Tuesday that it was partnering with the team behind Alibaba's Qwen AI models.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novo Nordisk Once-Weekly Insulin Icodec Poses Hypoglycemia Risk, FDA Says
Novo Nordisk Once-Weekly Insulin Icodec Poses Hypoglycemia Risk, FDA Says
May 22, 2024
01:43 PM EDT, 05/22/2024 (MT Newswires) -- Novo Nordisk's ( NVO ) insulin icodec for diabetes patients has an increased risk of causing low blood sugar levels, the US Food and Drug Administration said in a briefing document. The highest risk period for hypoglycemia with insulin icodec coincides with its peak glucose-lowering effect which occurs on days 2 to 4...
BRIEF-Milliporesigma Signs Definitive Agreement To Acquire Mirus Bio For US$600 Million
BRIEF-Milliporesigma Signs Definitive Agreement To Acquire Mirus Bio For US$600 Million
May 22, 2024
May 22 (Reuters) - Milliporesigma: * MILLIPORESIGMA: DEFINITIVE AGREEMENT TO ACQUIRE MIRUS BIO FOR US$600 MILLION * MILLIPORESIGMA: DEAL IS ANTICIPATED TO CLOSE IN Q3 OF 2024 Source text for Eikon: Further company coverage: ...
Market Chatter: BP Pauses Gas Project Talks With Venezuela After US License Expiration
Market Chatter: BP Pauses Gas Project Talks With Venezuela After US License Expiration
May 22, 2024
01:42 PM EDT, 05/22/2024 (MT Newswires) -- BP (BP) has halted talks with Venezuela on development of a gas project near the maritime border with Trinidad and Tobago after a US license expired expired in April, Reuters reported Wednesday, citing a company spokesperson. BP, which had been in talks to develop the Manakin-Cocuina field, a gas reservoir shared by the...
Amazon investors reject all 14 outside proposals
Amazon investors reject all 14 outside proposals
May 22, 2024
May 22 (Reuters) - Amazon.com ( AMZN ) investors voted against all 14 resolutions that would have requested the retailer disclose more about its carbon emissions, its directors' donations and form a committee to oversee artificial intelligence development, among other issues. Amazon ( AMZN ) announced the preliminary vote at its annual shareholder meeting on Wednesday, where all 12 directors...
Copyright 2023-2026 - www.financetom.com All Rights Reserved